openPR Logo
Press release

Global Remdesivir Market Growth Prospects, Future Industry Landscape 2032 | Gilead Sciences Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical

Remdesivir Global Market

Remdesivir Global Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Remdesivir Global Market Report 2023 identifies the The increasing prevalence of COVID-19 disease globally is a key factor driving the growth of the remdesivir market. According to the World Health Organization (WHO), there were 10,719,946 cases of COVID-19, including 5,17,337 deaths reported to the WHO on May 24, 2020, and this number is expected to grow shortly.

The global remedisiver market grew from $3.77 billion in 2022 to $4.95 billion in 2023 at a compound annual growth rate (CAGR) of 31.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The remedisiver market is expected to grow from $12.55 billion in 2027 at a CAGR of 26.2%.

Download Free Sample Of Remdesivir Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp

Major players in the remdesivir market are Gilead Sciences Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, and Dr. Reddy's Laboratories.

A key trend in the Remdesivir market includes the companies in the market are focusing on strategic partnerships and collaborations to help boost production. Major players are entering into partnership to expand their market and leverage each other's resources.

Read More On The Global Remdesivir Market Report Here:
https://www.thebusinessresearchcompany.com/report/remdesivir-global-market-report

The Remdesivir market is segmented -
1) By Route Of Administration: Oral, Intravenous
2) By Dosage Form: Tablets, Frozen Solution, Lypholized Solution
3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Remdesivir market.

The Business Research Company's "Global Remdesivir Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Remdesivir Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3253

The Table Of Content For The Remdesivir Market Include:
1. Executive Summary
2. Remdesivir Market Characteristics
3. Remdesivir Market Trends And Strategies
4. Remdesivir Market - Macro Economic Scenario
5. Remdesivir Market Size And Growth
……
27. Remdesivir Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Remdesivir Market
29. Remdesivir Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Remdesivir Market Growth Prospects, Future Industry Landscape 2032 | Gilead Sciences Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical here

News-ID: 3150883 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Remdesivir

Remdesivir Market to Reach USD 2.1 Billion by 2034
Pune, India, November 11, 2025 - The global Remdesivir Market is projected to expand from USD 1.3 billion in 2024 to USD 2.1 billion by 2034, registering a CAGR of 4.9 %, according to Exactitude Consultancy. Although initially propelled by the COVID-19 pandemic, the market is now stabilizing as governments and healthcare systems maintain strategic antiviral reserves, and manufacturers reposition remdesivir for broader RNA-virus and pandemic-preparedness applications. Download Full PDF Sample
Remdesivir Production Cost Analysis Report by Procurement Resource
Procurement Resource, a leading name in procurement intelligence and market research, is pleased to release its latest Remdesivir Production Cost Report. This detailed report is a crucial tool for pharmaceutical companies, active pharmaceutical ingredient (API) manufacturers, investors, and regulatory stakeholders seeking to gain a deep understanding of the economics, technologies, and market trends behind the production of Remdesivir. Remdesivir Production Cost Analysis Report: https://www.procurementresource.com/production-cost-report-store/remdesivir With growing global interest in antiviral treatments and
Remdesivir Market Growth, Trends, and Opportunities From 2025-2034
On April 22,2025, Exactitude Consultancy., Ltd. released a research report titled "Medical Alert Systems Market". This report covers the global Medical Alert Systems market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along
Remdesivir Market Report 2024: Data-Driven Insights on Trends and Opportunities
It is a nucleoside analog with antiviral activity, with an EC50 value of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and an EC50 value of 30 for murine hepatitis virus in delayed brain tumor cells nM. 2024 Market Report by QYResearch "Remdesivir - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030" provides an extensive examination of Remdesivir market attributes, size assessments, and growth projections through
Remdesivir Market Trends, Strategies, And Outlook By 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2102 The Business Research Company offers in-depth market insights through Remdesivir Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The remdesivir market size has grown exponentially in recent years. It will grow
Remdesivir Drugs Market Development, Trends, Segmentations Analysis 2020-2030
Remdesivir Drugs Market Research Outlook The study on the remdesivir drugs market is based on robust data-driven research models to identify, understand, and draw insights on the tactical, operational, and strategic factors shaping the consumer needs, want, demands, and attitudes. The study uses industry-validated statistical methods to translate data into actional insights useful for accurate decision-making for the clients and customers. Remdesivir Drugs Market: Industry Trends and Value Chain The report on the